Stereotactic ablative body radiotherapy (SABR) describes a radiotherapy (RT) technique
where high doses of radiation are precisely delivered to an extracranial target within the …

Lung cancer is a significant source of worldwide morbidity and mortality. 1 In the United
States, there will be an estimated 236,740 new cases and 130,180 lung cancer deaths in …

Stereotactic ablative radiotherapy (SABR), also known in older reports as stereotactic body
radiation therapy, represents an evolving and expanding radiation treatment option for many …

Lung cancer remains the leading cause of cancer related death in the United States with
mortality rates surpassing breast, prostate, brain, and colorectal cancers combined [1, 2] …

Currently, the standard of care for resectable, early-stage and functionally operable
nonsmall cell lung cancer (NSCLC) is complete surgical resection [1]. However, for elderly …

The standard of care for treatment of early-stage lung cancer continues to be definitive
surgery with lobectomy or pneumonectomy. However, there are patients who refuse surgery …

Early-stage non-small cell lung cancer (NSCLC) is on the rise due to the implementation of
screening guidelines for patients at risk for developing lung cancer. It is anticipated that as …

Stereotactic ablative radiotherapy (SABR), also called stereotactic body radiation therapy
(SBRT), has emerged as a promising treatment for early stage non-small cell lung cancer …

Stereotactic body radiation therapy (SBRT), also known as stereotactic ablative
radiotherapy, is a technique of external beam radiation that delivers precisely targeted …

Stereotactic body radiotherapy (SBRT) may be a potential alternative to surgical resection in
high-risk operable patients with early-stage non-small cell lung cancer (NSCLC). A number …